The Committee for Pediatric Solid Malignant Tumors in Kyushu area, Japan.
J Pediatr Surg. 2012 Dec;47(12):2205-9. doi: 10.1016/j.jpedsurg.2012.09.009.
The strategy used to treat pediatric renal tumors in Japan is based on the Japanese Wilms' Tumor Study (JWiTS) protocol, which was based on the National Wilms' Tumor Study (NWTS)-5 regimen. The regimen is characterized by an initial radical operation, followed by adjuvant chemotherapy and radiotherapy. Concerning the histological classification, a new classification based on the International Society of Pediatric Oncology (SIOP) classification was used beginning in 2008. The main points of revision are that the "blastemal predominant type" was classified as an independent category in the Wilms' tumor subtypes. The purpose of this study was to analyze the biological characteristics from the standpoint of the newly established histological classification.
From 1971 to 2005, 174 cases of Wilms' tumors treated with an initial operation followed by adjuvant therapy were re-evaluated by the new histological classification. Histologically, all these materials showed no secondary changes associated with adjuvant therapy.
According to the new classification, Wilms' tumors were classified into four subtypes, including the mixed type (n=112), epithelial type (n=17), mesenchymal type (n=15), and blastemal predominant type (n=26). The 5 year overall survival rates were as follows; mixed type (90.1%), epithelial type (100%), mesenchymal type (93.3%), and blastemal predominant type (65.4%).
The patients with blastemal predominant tumors demonstrated a significantly worse prognosis compared with those of other subtypes. The treatment strategy of blastemal predominant category should be distinguished from the other favorable subtypes.
日本儿科肾肿瘤的治疗策略基于日本威尔姆斯瘤研究(JWiTS)方案,该方案基于国家威尔姆斯瘤研究(NWTS)-5 方案。该方案的特点是初始根治性手术,然后进行辅助化疗和放疗。关于组织学分类,自 2008 年以来,开始使用基于国际小儿肿瘤学会(SIOP)分类的新分类。修订的主要要点是,“胚细胞瘤优势型”在威尔姆斯肿瘤亚型中被分类为一个独立的类别。本研究的目的是从新建立的组织学分类的角度分析生物学特征。
1971 年至 2005 年,对 174 例经初始手术加辅助治疗的威尔姆斯瘤病例进行了重新评估,采用新的组织学分类。从组织学上看,所有这些材料均未显示与辅助治疗相关的继发性变化。
根据新的分类,威尔姆斯瘤分为四种亚型,包括混合型(n=112)、上皮型(n=17)、间充质型(n=15)和胚细胞瘤优势型(n=26)。5 年总生存率如下:混合型(90.1%)、上皮型(100%)、间充质型(93.3%)和胚细胞瘤优势型(65.4%)。
胚细胞瘤优势型患者的预后明显差于其他亚型。胚细胞瘤优势型的治疗策略应与其他有利亚型区分开来。